Rajasthan govt official set himself on fire over work stress; in critical condition
An administrative officer at a government school in Rajasthan's Didwana-Kuchaman district allegedly attempted to kill self due to work-related stress on Monday, police said. Preliminary investigation suggests that the man was under severe pressure to update departmental records and meet administrative work targets.(Representative Image/Pixabay)
The incident took place in the veranda of the Government Higher Secondary School in Makrana town when Ramavtar Sharma (58), posted as the administrative officer, arrived on the premises carrying petrol in a plastic bottle, a police officer said.
He poured the petrol on himself and set himself on fire within the school premises, Station House Officer (SHO) Suresh Soni said.
A female sweeper working nearby noticed him engulfed in flames and raised an alarm, alerting other staff members.
She rushed outside screaming for help. Locals and school staff took Sharma to the government sub-district hospital on a motorcycle, Soni said.
Javed Alam, posted at the sub-district hospital, said the Sharma was given first aid.
"Due to the severity of burns and his critical condition, he was referred to Jawaharlal Nehru Hospital in Ajmer for advanced treatment," he said.
Preliminary investigation suggests that he was under severe pressure to update departmental records and meet administrative work targets, police said.
An inquiry has been initiated and statements of staff and family members are being recorded to ascertain the exact cause behind the suicide attempt, they added.
Discussing suicides can be triggering for some. However, suicides are preventable. A few major suicide prevention helpline numbers in India are 011-23389090 from Sumaitri (Delhi-based) and 044-24640050 from Sneha Foundation (Chennai-based).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
31 minutes ago
- NDTV
Lose Weight Without Quitting Sugar: Yes, You Can. Nutritionist Explains How
For many of us, the day simply does not begin without a hot cup of chai - sweetened with a teaspoon or two of sugar. But if you are trying to lose weight, you have probably been told to cut sugar out of your diet entirely. While that advice may be popular, it is not completely accurate. According to Dr Sidhant Bhargava, nutritionist known to have worked with celebrities like Alia Bhatt, Sara Ali Khan, and Ananya Panday, you can still lose weight without giving up sugar altogether. The key lies in understanding how weight loss truly works. Let us explore the science behind this claim and see how you can enjoy your regular chini-wali chai while still achieving your fitness goals. Also Read: Can Parathas Be Healthy? Yes, If You Try These Protein-Rich, No-Oil Recipes Photo Credit: Pixabay Sugar Is Not The Enemy. Excess Calories Are: Dr Bhargava points out that 1 gram of sugar contains 4 calories, so 1 teaspoon (5 grams) adds only about 20 calories to your drink. If you are adding one or two teaspoons to your tea, that is merely 20-40 calories, nowhere near enough to derail your weight loss progress. "20-30-40 calories do not really matter. Overall calorie deficit matters," he says in one of his YouTube shorts. A report by the Cleveland Clinic suggests that the average adult needs 1,800 to 2,500 calories per day, depending on age, sex, and activity level. So yes, your spoon of sugar is barely a drop in that bucket. What really matters is your total energy balance how many calories you consume versus how many you burn, not a single ingredient in isolation. Also Read: Why Coffee Might Be The Pre-Workout Boost You've Been Missing What Is A Calorie Deficit And Why Does It Matter: A calorie deficit means consuming fewer calories than your body needs to maintain its current weight. This shortfall forces your body to use its fat stores for energy, resulting in weight loss. Experts agree that no matter what diet you follow, whether it is keto, low-carb, intermittent fasting, or anything else, you will only lose weight if you are in a calorie deficit. Cutting sugar alone will not help if your overall calorie intake remains too high. The science is clear: how much calorie you consume and how much you burn drives the total fat loss from your body. The Real Culprit: Sugar + Fat Combo Dr. Bhargava further explains that the problem arises when sugar is combined with fat, especially in traditional Indian sweets like gulab jamun, kaju katli, or halwa. These are loaded with ghee, khoya, or oil, and can pack hundreds of calories per serving. According to fat has 9 calories per gram, more than double the 4 calories per gram found in sugar or protein. This combo is not only calorie-dense but also spikes insulin, promoting fat storage, especially if eaten frequently. Also Read: 6 Classic Indian Breakfast Upgrades That Actually Burn Fat Photo Credit: iStock How To Enjoy Sugar And Still Lose Weight Here are some practical tips to help you enjoy life without derailing your progress: 1. Track your calories: Research shows that people who log their meals are more likely to lose weight and keep it off. 2. Focus on nutrient-dense foods: Prioritise fruits, vegetables, whole grains, and lean protein sources. These keep you full longer and reduce cravings. 3. Limit high-fat sugary foods: Sweets are fine occasionally, just not every day. Savour a small portion mindfully when you do indulge. 4. Exercise regularly: Physical activity boosts your daily calorie burn and helps preserve lean muscle, which supports metabolism. 5. Be consistent: You do not have to be perfect. Long-term, sustainable habits are far more effective than short bursts of extreme diets. Also Read: 6 Forgotten Indian Superfoods That Help Lose Weight... Without Any Special Diet Photo Credit: iStock Final Thoughts: No Need To Fear Sugar A spoon of sugar in your chai is not the villain in your weight loss journey. What matters most is your overall calorie intake and expenditure. So instead of fearing sugar, focus on balance, awareness, and consistency. Weight loss is not about cutting out the things you enjoy, it is about making informed choices that you can sustain. Advertisement About Somdatta Saha Explorer- this is what Somdatta likes to call herself. Be it in terms of food, people or places, all she craves for is to know the unknown. A simple aglio olio pasta or daal-chawal and a good movie can make her day. For the latest food news, health tips and recipes, like us on Facebook or follow us on Twitter and YouTube. Tags: Sugar Weight Loss Calorie Deficit Show full article Comments
Economic Times
5 hours ago
- Economic Times
Wockhardt activates Zaynich push, eyes global licensing deals
Habil Khorakiwala Mumbai: Wockhardt is working on ambitious plans for Zaynich, a combination of zidebactam and cefepime that was found to be effective during clinical trials to fight superbugs or bacterial infections that show resistance to a range of existing antibiotic treatments. The drug maker has hired merchant bankers to identify possible out-licensing deals for the novel product, chairman Habil Khorakiwala told ET in an exclusive interview. Wockhardt in March sought regulatory approval for Zaynich in India and expects its commercial launch in the first half of '26. In the US, it plans to file for regulatory clearance in August.'We will get into the US market by the end of FY26 or latest by the second half of 2026 and Europe will be a year later,' Khorakiwala said. Zaynich is seen as a game-changing drug against drug-resistant gram-negative pathogens. These pathogens are difficult to kill. Zaynich is estimated to have a market opportunity of about $9 billion. Around a million people die due to multidrug resistance in India every year, while worldwide, the number is 5 million, Khorakiwala said. Currently there are very few effective treatments available for these infections. Mumbai-based Wockhardt completed the Phase-3 clinical trials for Zaynich earlier this year. In January it announced that the drug demonstrated more than 97% clinical efficacy in treating serious infections of bacteria resistant to carbapenem antibiotics, which are often used as a last resort to treat severe infections. The company is prepared to go solo to market Zaynich in India, the US and other markets if the licensing proposals do not meet its expectations on valuation, Khorakiwala said without revealing the valuation he is looking for.'We will evaluate how to go about and take an appropriate call, so we are keeping two options fully alive,' Khorakiwala said. 'One option is licensing out, the other is in some markets like in India we are doing ourselves,' he said. 'The US is another market where we are thinking of the possibility (of marketing on its own); you don't need too much marketing cost and you have talent available.'Wockhardt also plans to fully outsource manufacturing for the Western markets to eliminate issues related to the US Food and Drug Administration, and channel its focus on the clinical and research part.'For manufacturing, plenty of options are available in Europe and the US, so I am not getting into FDA-related manufacturing problems,' said Khorakiwala. 'Zaynich — we are manufacturing everything in Europe.' It will adopt the same strategy to outsource most of the manufacturing for all its other new company had in the past faced some issues with the US FDA over alleged violations of good manufacturing practices. 'That (FDA-elated manufacturing problems) was our weakness, and I am eliminating that completely from my western markets to only focus on the clinical and research part,' he said. COMPANY TURNAROUND Wockhardt has seen a remarkable turnaround in its stock price in the past year and a half with renewed confidence from investors, with developments on Zaynich being among the key drivers. Its stock price more than doubled in the last 12 months and increased over three-and-a-half times since January 2024. The shares closed at `1,713.20, up 4.5%, on BSE Monday. 'We have revisited what are the strengths and what are the opportunities — one obviously is our new drug discovery — in India and worldwide,' said also stressed on the company's focus on biologics as another key growth driver.'Within biologics we will stay in insulin and GLP1; we are not going to touch the rest of the biologics like monoclonal antibodies and others. Because we feel it is important to be focused,' he does not see itself as a generic company, he said. 'In fact, in the US we are exiting generics … we will be focused on the biological area and NCE (new chemical entities) and strictly on antibiotics,' he chairman said his research pipeline has a range of antibiotics under development, including early-stage work on an oral version of Zaynich. PRICING STRATEGY Khorakiwala said the treatment cost with most new products including antimicrobials launched in the last 10 years in the US has been in the range of $10,000-15,000 per treatment. Zaynich will also hover in that range in the US but in India, the price will be significantly lower, he said.
Time of India
7 hours ago
- Time of India
From clinics to code, doctors in Gujarat take the startup route
Slug: National Doctors' Day Ahmedabad: When Dr Jeet Naik, a dental surgeon, could not find affordable, quality preformed primary molar stainless steel crowns made in India, he did not wait for the market to catch up. Instead, he built the solution himself. "Even before I set up my practice, I was working on tech to make crowns accessible to the paediatric and adult population. Once the prototype worked, I started Rainbow Crowns," said Dr Naik, co-founder of the Ahmedabad-based startup incubated at iHub. After success in Gujarat, the venture has expanded across India, and now aims at the global market. On National Doctors' Day, observed on July 1 in honour of legendary physician Dr B C Roy, a different kind of doctor is emerging: one who wears both a white coat and an innovator's cap. Across Gujarat's startup ecosystem, more doctors are stepping into the entrepreneurial space, driven by a firsthand understanding of gaps in healthcare, from surgical devices to patient apps. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad While some startups, such as Modified Energy Device, target niche clinical needs, others tackle everyday frustrations. Dr Abhijeet Salunke, an orthopaedic oncosurgeon, is the co-founder of Intentio biopsy device. "Collecting bone and marrow samples accurately is crucial for diagnosing cancers and infections," he said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Memperdagangkan CFD Emas dengan salah satu spread terendah? IC Markets Mendaftar Undo "We worked for years to perfect our biopsy gun, which is now patented." Dr Om Lakhani, an endocrinologist, built an app to assist diabetic patients with insulin management. Still in beta, the app helps users plan their insulin intake and track sugar levels based on dietary inputs. "This is where medical knowledge and AI intersect meaningfully," he said. Even beyond med-tech, doctors are creating solutions for modern lifestyles. A startup named Snakss, founded by healthcare professionals, addresses quick commerce food delivery — an idea born from their own long hospital shifts and dietary challenges. The state's innovation ecosystem is now actively promoting such crossover ventures. Dr A N Kadri, executive director of the State Health Resource Centre (SHRC), said that awareness campaigns about startup opportunities are now held across medical, dental, and physiotherapy colleges. "We are building an environment where doctors can think beyond clinics," he said. Hiranmay Mahanta, CEO of iHub, added that all 12 govt medical colleges are part of Gujarat's Student Startup and Innovation Policy (SSIP). "We are seeing a clear rise in student-led research and doctor-driven innovation," he said.
